<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01354964</url>
  </required_header>
  <id_info>
    <org_study_id>2008-225</org_study_id>
    <nct_id>NCT01354964</nct_id>
  </id_info>
  <brief_title>Effect of Vitamin D Repletion on Insulin Resistance and Systemic Inflammation</brief_title>
  <official_title>Effect of Vitamin D Repletion on Insulin Resistance and Systemic Inflammation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Albert Einstein College of Medicine, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Albert Einstein College of Medicine, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to study the effects of Vitamin D supplementation on the
      body's response to insulin (a hormone that controls blood sugar), on inflammation and/or on
      specific cells and processes in fat tissue, and on function of skeletal muscle and joints.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Over the last several years, studies have shown that low vitamin D levels may increase risk
      of development of Type 2 Diabetes. The investigators will administer vitamin D3
      (Cholecalciferol) to nondiabetic, insulin resistant subjects with vitamin D deficiency (total
      vitamin D levels &lt; 20 ng/ml) to increase the level of vitamin D initially to 30-50ng/ml and
      then to higher normal range of 51-75 ng/ml. The investigators will study its effects on
      insulin action, adipose tissue inflammation, and musculoskeletal function.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2009</start_date>
  <completion_date type="Anticipated">March 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hepatic insulin sensitivity</measure>
    <time_frame>2 and 4 months</time_frame>
    <description>We will examine endogenous glucose production to assess hepatic insulin sensitivity.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Peripheral insulin sensitivity</measure>
    <time_frame>2 and 4 months</time_frame>
    <description>We will examine the rate of glucose uptake to determine peripheral inslin sensitivity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adipose tissue inflammatory markers/Cytokines in plasma</measure>
    <time_frame>2 and 4 months</time_frame>
    <description>Inflammatory markers-PAI-1, IL-6, TNF-a, iNOS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neuropsychological Testing</measure>
    <time_frame>4 months</time_frame>
    <description>We will conduct neuropsychological testing to assess cognitive function.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Insulin Resistance</condition>
  <arm_group>
    <arm_group_label>Vitamin D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitamin D</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D</intervention_name>
    <description>Weekly oral vitamin D drops, weight-based calculated dosage, taken on the same day each week for 4 months.</description>
    <arm_group_label>Vitamin D</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 21-60 years old

          -  Serum 25(OH)D&lt;20ng/ml

          -  Insulin Resistant based on HOMA-IR score of &gt;3

          -  Able and willing to provide informed consent

          -  BMI 27-35

        Exclusion Criteria:

          -  FPG greater than or equal to 126 mg/dl or 2-hour-OGTT plasma glucose greater than or
             equal to 200 mg/dl

          -  Diagnosed diabetes mellitus

          -  HIV/AIDS

          -  History of any cancer

          -  Sarcoidosis

          -  Alcohol or substance abuse

          -  Cushing's syndrome

          -  Primary hyperparathyroidism

          -  Nephrolithiasis

          -  Pregnancy or breastfeeding

          -  Regular visits to a tanning salon

          -  Hypercalcemia or hypocalcemia

          -  Untreated or uncontrolled hypertension

          -  Any chronic illness requiring medication, other than arthritis, hypertension and
             hyperlipidemia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Preeti Kishore, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Albert Einstein College of Medicine, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stephanie M Lawrence, BS</last_name>
    <phone>718-430-2903</phone>
    <email>stephanie.lawrence@einstein.yu.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Albert Einstein College of Medicine of Yeshiva University</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10461</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Lawrence, BS</last_name>
      <phone>718-430-2903</phone>
      <email>stephanie.lawrence@einstein.yu.edu</email>
    </contact>
    <investigator>
      <last_name>Preeti Kishore, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 12, 2011</study_first_submitted>
  <study_first_submitted_qc>May 16, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 17, 2011</study_first_posted>
  <last_update_submitted>May 16, 2011</last_update_submitted>
  <last_update_submitted_qc>May 16, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 17, 2011</last_update_posted>
  <responsible_party>
    <name_title>Preeti Kishore</name_title>
    <organization>Albert Einstein College of Medicine</organization>
  </responsible_party>
  <keyword>Glucose Metabolism Disorders</keyword>
  <keyword>Insulin Resistance</keyword>
  <keyword>Endocrine System</keyword>
  <keyword>Vitamin D</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

